Chemistry-Powered “Breathing” Membrane Opens and Closes Tiny Pores on Its Own
On Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that…
-
-
A world-first mouse that makes gene activity visible
On Jan. 31, 2026, a research team from the Institute of Science Tokyo reported they became the first…
-
CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Vaccine
Harsh Flu Season May Be Driven by New Variant K
On Dec. 16, 2025, researchers from the International Vaccines Access Center (IVAC) reported that as of mid-December, flu,…
-
Japanese Scientists Reproduce human neural circuits showing crucial role of the thalamus
On Dec. 12, 2025, a Japanese research team announced it has successfully reproduced the human neural circuit in…
-
‘Mind-captioning’ AI decodes brain activity to turn thoughts into text
On Nov. 5, 2025, researchers announced that reading a person’s mind using a recording of their brain activity…
-
Japan declares a flu epidemic — what this means for other nations
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
-
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance”
On Oct. 6, 2025, The Nobel Assembly has awarded the Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred…
-
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
-
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
-
Japan draws up $700 Million Fund to attract foreign researchers
On Jun. 13, 2025, the Japanese government unveiled a 100 billion yen ($700 million) policy package designed to…
-
Biology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
FDA clears first blood test for Alzheimer’s detection
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
-
Japan first in the world to approve Dupixent (dupilumab) for chronic spontaneous urticaria
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted traditional approval for LEQEMBI (lecanemab-irmb) for the treatment of Alzheimer’s disease
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
Disease | FDA | Neurology | Therapeutics
Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
-
Moderna announced first participant dosed in phase 1/2 study of COVID-19 vaccine in Japan led by Takeda
On Jan. 21, 2021, Moderna announced that the first participant has been dosed in the Phase 1/2 study…
-
GABA-enriched tomato first CRISPR-edited food to enter market launched in Japan
On Dec. 11, 2020, Sanatech Seed Co, and sales partner Pioneer EcoScience, announced the commercial sales of Sicilian…
-
Amgen established Amgen Astellas BioPharma as wholly-owned affiliate In Japan
On Apr. 1, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
-
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
-
Takeda Pharmaceutical acquired Shire for $62 Billion
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
-
Living bacteria reported riding with earth’s upper air currents
On Jan. 11, 2016, National Aeronautics and Space Administration (NASA) research scientist David J. Smith reported finding that…
-
The first use of artificial blood in a patient takes place at the University of Minnesota Hospital
On Nov. 20, 1979, Dr. Robert Anderson from the University Hospital injected Fluosol, a blood substitute developed in…
